Entrepreneurship, Innovation
DETERA Therapeutics, a peptide to prevent crescentic glomerulonephritis (CGN)
… crescentic glomerulonephritis (CGN) Entrepreneurship Innovation As kidney disease continues to rise worldwide, the start-up DETERA Therapeutics is … significantly reduced. This will generate savings for the public health system," says the director. To raise …Published on: